Latest filing published 31 Mar 2009 for GENENTECH INC, €59k.
No signal scores available.
Robert E. Andreatta discloses dealings in Genentech Inc to SEC (Form 4). In total, 2 filings cover trades dated 26 March 2009.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 31 March 2009 came the latest disclosure, a transaction for €59k in Genentech Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations